In vitro transcriptase activity of three group I temperature-sensitive (ts) mutants of vesicular stomatitis virus restricted at 39 C was restored by Lprotein fractions derived from wild-type (wt) vesicular stomatitis virion nucleocapsids. Soluble NS protein from wt nucleocapsids did not reconstitute restricted transcription of the group I RNA-ts mutants. NS protein activity, but not L protein activity, was purified from the group I ts mutants; this NS fraction always displayed the wt phenotype in reconstitution assays. Neither the L nor the NS protein was capable of restoring the defective transcriptive activity of the group IV vesicular stomatitis virus mutant tsW16B.
Vesicular stomatitis (VS) virus, particularly the Indiana serotype, is the prototype of the negative-strand RNA rhabdoviruses (28) . An endogenous nucleocapsid RNA-dependent RNA polymerase has been shown to transcribe the VS viral genome in vitro (1) and in vivo (14, 18) and to give rise to monocistronic mRNA species which can be translated into specific viral polypeptides (5, 16) . There are five polypeptides present in the virion, each of which serves a specific structural or enzymatic function (30) . The nucleocapsid of VS virus is composed of three proteins in association with virion RNA. All three of the nucleocapsid proteins, L, NS and N, are required for transcriptase activity (9) (10) (11) . The RNA-N protein nucleocapsid complex serves as template (9) . High-ionic-strength buffers solubilize the L and NS proteins, resulting in loss of transcriptase activity of the nucleocapsid (9, 15) ; functional transcriptive activity can be reconstituted when both L and NS proteins reassociate with the nucleocapsid template (10, 11) , provided that the recombined enzyme and template are both derived from antigenically closely related rhabdoviruses (3) . The G and M proteins of the virion membrane do not appear to be required for transcription (4, 9, 27) .
Temperature-sensitive (ts) mutants of VS (Indiana) virus fall into five well-defined genetic complementation groups (8, 13, 22) ; some evidence has been presented for a sixth complementation group (25; C. R. Pringle, personal communication) . Mutants in complementation groups I and IV exhibit restricted RNA synthesis (RNA-phenotype) in vivo at nonpermissive temperature, as do certain mutants in complementation group II (23, 24, 31) . Group I ts mutants also are restricted in transcription in vitro, albeit with varying degrees of leakiness (26) . Hunt and Wagner (15) have previously demonstrated that the transcription defect in three group I ts mutants is attributable to thermosensitivity of the solubilized transcriptase enzyme and not the sedimentable nucleocapsid template. This observation was confirmed by Ngan et al. (19) , who also provided evidence that restricted transcription of a single RNAgroup IV mutant, ts W16B, was not attributable to a soluble enzyme component but might be due to a defective nucleocapsid template. Other group IV mutants do not exhibit a phenotype restricted in transcription in vitro (26) .
The present experiments were designed to determine which of the two proteins, L and NS, comprising the transcriptase complex (11) are responsible for restricted in vitro RNA synthesis of VS virus ts mutants of complementation group I. Comparative studies were also performed with the transcriptase-restricted group IV mutant tsW16B. Proteins L and NS were fractionated chromatographically and tested alone or in combination for their capacity to restore transcriptase activity to nucleocapsids devoid of L and NS proteins or to complement the defect in unfractionated mutant virions. respectively. Cultures were infected at a multiplicity of 1 PFU/cell, and virions were harvested 16 to 18 h (wt) or 20 to 24 h (ts mutants) postinfection. Purified B virions were prepared by differential, rate zonal, and equilibrium centrifugation, as described previously (11) and stored on ice (ts mutants) or at -18 C (wt virus) until needed. The ts mutant preparations were always used as soon as possible after harvesting.
Virus was titrated by plaque assay on monolayers of L cells at 31 C (29) . No wt plaque revertants were detected at 39 C in preparations of tsG13 (I), tsG16 (I), or tsG114 (I), although very small, faint plaques, quite unlike wt plaques, could sometimes be detected with tsG13 (I) at 39 C up to 10-5 of the PFU level at 31 C. Plating of tsW16B at 39 C resulted in plaques with wt morphology at titers of approximately 10-4 of the PFU obtained at 31 C. This apparent high reversion rate of tsW16B (IV) has been reported previously (8) , but nevertheless we decided to use this mutant because it was the only wellcharacterized group IV mutant with a thermosensitive transcriptive phenotype in vitro.
Preparation of L and NS protein fractions. L and NS proteins were fractionated essentially as described by Emerson and Yu (11) . Virus suspended in 10 mM Tris-hydrochloride, pH 7.4, containing 15% (vol/vol) glycerol was treated with an equal volume of 2 x Triton-high salt solubilizer (2 x Triton-HSS = 18.7% glycerol-1.44 M NaCl-1.2 x 10-3 M dithiothreitol [DTT]-3.74% Triton X-100-10-2 M Tris-hydrochloride, pH 7.4) for 60 min at 0 C. The supernatant fraction ( 15 ml) obtained by centrifugation for 120 min at 125,000 x g was kept overnight on ice and then dialyzed for 3 h against two 300-ml changes of column buffer (75 ml of glycerol, 3 ml of 20% Triton X-100, 9 mg of DTT, and 222 ml of 5 x 10-2 M Trishydrochloride, pH 7.4) containing 0.1 M NaCl. This 3-h dialysis procedure, rather than the overnight dialysis -employed previously (11) , was used in an attempt to stabilize the L-protein activity. The proteins were then fractionated by phosphocellulose and DEAE-cellulose chromatography by the method already described (11) , with the exception that a step-elution procedure was used to purify the NS on the DEAE-cellulose columns, which were washed with 0.1 M NaCl-column wash followed by 0.4 M NaCl-column wash to elute the NS-containing fraction. The protein content of the L and NS fractions was always examined by electrophoresis on 7.5% polyacrylamide-SDS gels to ensure that such fractions did indeed contain L or NS proteins and that there was no cross-contamination. Small amounts of G and M protein, as reported by Emerson and Yu (11) , contaminate both the L and NS fractions.
Template preparation. Nucleocapsid template was prepared essentially free of L and NS protein by a published method (11) . Virions labeled with '4C-amino acids were disrupted by addition of an equal volume of 2x HSS, and the released nucleocapsids were concentrated by centrifugation onto a Renografin pad. At this point, the procedure was modified, and the nucleocapsid band was collected and applied directly to an agarose (Bio-Gel A-5m) column equilibrated with 10% glycerol-1 M NaCl-0.1% Triton X-100-10-4 M DTT-0.01 M Tris-hydrochloride, pH 7.4. Fractions of approximately 2 ml were collected. The excluded fractions containing the labeled nucleocapsid were pooled and layered over two concentrations of glycerol prior to centrifugation at 125,000 x g (11) . The nucleocapsids were removed along with the 100% glycerol pad and stored at -18 C until used.
Transcriptase assays. Transcriptase assays of unfractionated virus, or virus separated into pellet and supernatant fractions and then recombined, were carried out as described by Hunt and Wagner (15) . To assay the capacity of L and/or NS protein fractions to restore transcriptive activity to inactive agarose template, 1 
RESULTS
The ts defect in tsG114 (I). Table 1 summarizes experiments on the comparative temperature sensitivity of the transcriptase of VS virus wt and tsG114 (I) as well as the recombined pellet (P) and supernatant (SN) fractions after dissociation in Triton-HSS. As noted, the transcriptase thermosensitivity of tsG114 (I) resides in the SN fraction rather than the nucleocapsid pellet, to at least the same degree as we reported (15) for tsG13 (I) and tsG16 (I). RNA synthesis at the nonpermissive temperature of 39 C was 15 to 25% of that at permissive 31 C when wt P or ts P was reconstituted with wt SN, whereas the amount of RNA synthesized at 39 C with ts SN recombined with either wt P or ts P was only 2 to 3% of the permissive level. These data confirm that the transcription defect in tsG114 (I), as in the case of tsG13 (I) and tsG16 (I), is in the supernatant fraction. In vitro "complementation" of ts mutants by wt L or wt NS proteins. Another approach to the problem ofthe nature ofthe transcriptase lesion in group I mutants is to test whether addition of either wt L-or wt NS-containing fractions to such a mutant results in restoration of transcriptive activity at 39 C in vitro by competing with defective ts proteins for template attachment sites. In these experiments, the L, G, M, and NS proteins were first solubilized from the template by addition of 2 x Triton-HSS but not fractionated. Then either wt L-or wt NS-containing fractions were added before the salt concentration was lowered, prior to the initiation of transcription. The purpose of this procedure was to ensure that the added wt L or wt NS protein did not have to compete with ts L or ts NS protein still bound to the template. A group IV mutant (tsW16B), which has a ts transcriptive activity in vitro, was similarly tested as a control.
Before the complementation experiments were carried out, the wt L and wt NS fractions to be used were assayed with a wt template fraction to test their activity. The virus preparations that were to be tested for their ability to be complemented were then diluted such that the expected amount of [3H]UMP that could be. incorporated in a transcriptase assay at 31 C was in the same range as the known capability of the wt L and wt NS fractions to catalyze RNA synthesis. This was done to provide a sufficient concentration of wt L or wt NS protein in the complementation assays to support a significant amount of RNA synthesis at 39 C relative to 31 C. In all experiments, wt VS virus was used as a control, and the protein concentrations of mutants and wt were adjusted to be approximately the same. The results of the above experiments are shown in Fig. 2 and Table 2 . Addition of wt L or wt NS fractions to disrupted but unfractionated wt virions rarely had any significant effect on
[3H]UMP incorporation at 31 C ( Fig. 2A-C (Fig. 2F and I) . [The slight stimulation in RNA synthesis of tsWl6B (IV) when supplemented with a wt NS fraction, noticeable in Fig. 21 , was not always observed.] However, inclusion of a wt L fraction in the transcriptase assay resulted in significant recovery of activity at 39 C in all the complementation group Its mutants tested (Table 2 ; Fig. 2E ). This stimulation was specific for group I mutants, as [3H]UMP incorporation by the group IV mutant, tsW16B, which has a temperature-sensitive transcriptive activity in vitro (19) , was as temperature sensitive in the presence as in the absence of an added wt L fraction (Table 2 ; Fig.   2H ). Whenever tsWl6B (IV) was tested, a group I mutant was always assayed simultaneously to ensure that the added wt L protein was active.
In vitro complementation between group I mutants and tsW16B(IV). To verify that tsWl6B(IV) has a different lesion in in vitro assays compared to the group I mutants and thus to check that the failure of wt L protein fractions to restore transcriptive activity at 39 C to this mutant was probably due to a group-specific effect, we assayed in vitro transcriptase complementation of the type described by other workers (6, 19 experiment, such as observed with tsWl6B-(IV), is difficult to interpret because it could be due to the fact that proteins of some mutants may be so firmly bound to the nucleocapsid template that added wt proteins could not compete efficiently. Therefore, this experiment tells us little about the lesion in tsW16B(IV) transcription except that it is unlikely to be due to a defective L protein.
The inability to recover L-protein activity from tsG16 (I) and tsG114 (I) implies that the L protein of these mutants is not only thermosensitive but is also more susceptible to inactivation than is wt L protein. However, this does not mean that all group I mutants of VS virus possess a labile L protein. Some group I mutants exhibit a highly thermosensitive phenotype at 39 C, whereas others are much less restricted (15, 26) . Some group I mutants also transcribe the viral genome completely in vivo at temperatures restrictive for productive infection (12, 21) . In addition, assays of in vitro transcriptase activity may not always be a reliable model for the in vivo system. Primary transcription in vivo in the presence of cycloheximide (i.e., transcription of the input nucleocapsid) is far less temperature sensitive than in vitro transcription (12) . Moreover, there is evidence from studies of viral protein VOL. 18, 1976 on July 6, 2017 by guest http://jvi.asm.org/ Downloaded from synthesis that in vivo transcription is complete in cells productively infected at 37 C, whereas the VS viral genome is completely transcribed at 28 C but only 25 to 50% transcribed at 37 C in vitro (2) . However, these results are not necessarily incompatible with the hypothesis that all group I mutants are defective in transcription. For example, a mutant could make faulty RNA at restrictive temperature or could synthesize a faulty transcriptase at 39 but not at 31 C (12) . In either case, productive infection would abort at restrictive temperature. The situation is further complicated by the suggestion of several groups (7, 20, 24) of possible coordinated transcription and replication; however, much of these data are difficult to interpret. Presumably, however, a lesion in replication may also affect transcription secondarily.
Despite these reservations, it seems quite evident that in group I VS virus ts mutants: (i) the defective component in temperature-restricted transcription is the L protein, and (ii) the NS protein as well as the ribonucleocapsid and its N protein are functionally intact and phenotypically identical to that of wild type. The defective component in transcription in vitro of the group IV mutant tsW16B is more difficult to identify, but is not likely to be the L protein.
